China Aoxing Pharmaceutical Company
China Aoxing Pharmaceutical Company, Inc. is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.
It also has a strategic alliance with American Oriental Bioengineering, Inc. (NYSE: AOB) to develop and market various narcotic drugs in China
See more information about China Aoxing Pharmaceutical Company
China Aoxing posts 27pct rise in annual revenue
China Aoxing Pharmaceutical today reported year-end results to June 30 with revenues up 27 percent to US$8,941,907 and gross profit up 18 percent to US$3,806,246.
The company attributes the increase to increased marketing efforts, improved brand recognition and effective pricing strategy.
The company also invested more in research and development, raising its spend from US$700,202 in fiscal year 2008 to US$722,567 in fiscal year 2009. Development programs include Oxycodone, Tilidine, Codeine Phosphate and Buprenorphine.
Mr. Zhenjiang Yue, Chairman and Chief Executive Officer of China Aoxing, said: "We are very pleased with our 2009 fiscal year financial and business results. We revised our capital structure and improved our financial condition significantly, forming an important basis of our future business expansion."
Other China Aoxing Pharmaceutical Company news
- China Aoxing receives SFDA approval for clinical trial of abuse resistant Opioid
2009-09-18 - China Aoxing Pharma gets renewal of GMP certification for capsule production facility
2009-07-24
